Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02365714 · ClinicalTrials.gov registry record · Phase 1
CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)
A Phase 1 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02365714: Clinical Trial Phase 1 study, sponsored by Georgetown University.
NCT02365714 is a Phase 1 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02365714, a Phase 1 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will prospectively evaluate the technical feasibility, acute toxicity, late effects and oncologic outcomes of CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) in early stage breast cancer. It will evaluate quality of life (QOL) issues as they relate to treatment-related side effects and cosmetic results.
Primary Outcome
Only one of two patients were able to undergo CyberKnife SAPBI. We are measuring the percentage of enrolled subjects in whom CyberKnife SAPBI PBI is technically feasible to deliver and complete treatment
Interventions
- RADIATION CK Stereotactic Accelerated Partial Breast Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-01 |
| Phase | Phase 1 |
Why NCT02365714 stopped before completion
NCT02365714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which CK Stereotactic Accelerated Partial Breast Irradiation is the first listed.
NCT02365714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02365714 about?
NCT02365714 is a clinical study titled "CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)". This study will prospectively evaluate the technical feasibility, acute toxicity, late effects and oncologic outcomes of CyberKnife Stereotactic Accelerated Partial Breast Irradiation (CK-SAPBI) in early stage breast cancer. It will evaluate quality of life (QOL) issues as they relate to treatment-r...
What is the current status of trial NCT02365714?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2015-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02365714?
The interventions under investigation include: CK Stereotactic Accelerated Partial Breast Irradiation (RADIATION).
Who is sponsoring clinical trial NCT02365714?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02365714's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia